Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2026-03-03 @ 2:21 AM
Study NCT ID:
NCT01340833
Status:
COMPLETED
Last Update Posted:
2017-11-13
First Post:
2011-04-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Determination of the Absolute Bioavailability of GSK2118436 Following a Single Oral Dose Co-Administered With an Intravenous Radiolabelled Microtracer of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-06-08
Start Date Type:
ACTUAL
Primary Completion Date:
2011-09-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-09-12
Completion Date Type:
ACTUAL
First Submit Date:
2011-04-14
First Submit QC Date:
None
Study First Post Date:
2011-04-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-11-08
Last Update Post Date:
2017-11-13
Last Update Post Date Type:
ACTUAL